miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 586, Issue 19, Pages 3309-3316
Publisher
Wiley
Online
2012-07-20
DOI
10.1016/j.febslet.2012.06.054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription
- (2011) Toby Hulf et al. BMC GENOMICS
- Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma
- (2011) Qing Xie et al. CANCER
- Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
- (2011) Jin Hou et al. CANCER CELL
- miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
- (2011) J.-K. Park et al. CANCER RESEARCH
- MicroRNA-423 promotes cell growth and regulates G 1 /S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma
- (2011) Jun Lin et al. CARCINOGENESIS
- miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway
- (2011) Sheng Tan et al. FEBS LETTERS
- Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma
- (2011) Qiao Ying et al. HEPATOLOGY
- Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation
- (2011) Zhong-Bo Han et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma
- (2011) Shupeng Liu et al. JOURNAL OF HEPATOLOGY
- miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened
- (2011) Xiao-Hui Huang et al. JOURNAL OF PATHOLOGY
- Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
- (2011) Mingquan Chen et al. PLoS One
- Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma
- (2011) Iman I. Ramzy et al. Arab Journal of Gastroenterology
- SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
- (2010) Yan Jia et al. Epigenetics
- A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma
- (2010) Chunxian Zeng et al. HEPATOLOGY
- Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
- (2010) Ling-Min Kong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Molekulare Progressionsmechanismen der humanen Hepatokarzinogenese
- (2010) K. Breuhahn PATHOLOGE
- MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
- (2008) Queenie W.–L. Wong et al. GASTROENTEROLOGY
- Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis
- (2008) Tanja Nussbaum et al. HEPATOLOGY
- miR-122, a paradigm for the role of microRNAs in the liver
- (2008) Muriel Girard et al. JOURNAL OF HEPATOLOGY
- Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
- (2008) Patrick Arbuthnot WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started